Phase 2 REC-4881 Data Show Polyp Burden Reductions in FAP
New Phase 2 data presented at CGA-IGC show deep, durable polyp burden reductions in FAP, with activity across the GI tract and in larger, higher-risk polyps.
New Phase 2 data presented at CGA-IGC show deep, durable polyp burden reductions in FAP, with activity across the GI tract and in larger, higher-risk polyps.